Literature DB >> 17828618

The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.

Tomiyasu Arisawa1, Tomomitsu Tahara, Tomoyuki Shibata, Mitsuo Nagasaka, Masakatsu Nakamura, Yoshio Kamiya, Hiroshi Fujita, Masahiko Nakamura, Daisuke Yoshioka, Yuko Arima, Masaaki Okubo, Ichiro Hirata, Hiroshi Nakano.   

Abstract

We investigated the association between ulcerative colitis (UC) and polymorphisms of IL-17A (rs2275913, G-197A) and IL-17F (rs763780, 7488T/C) genes. We employed the multiplex PCR-SSCP method to detect gene polymorphisms. Both the numbers of -197A (IL-17A) and 7488T (IL-17F) alleles were significantly correlated to the development of UC. The frequencies of -197A/A and 7488T/T genotypes in the UC group were significantly higher than those in the non-UC group. An adjusted analysis revealed that -197A and 7488T alleles were independent risk factors for the developing UC. In addition, both polymorphisms were significantly associated with the pancolitis phenotype. Furthermore, -197A allele was significantly correlated to the chronic relapsing phenotype and -197A/A homozygote was more frequent in steroid-dependent cases, whereas 7488T allele was correlated with the chronic continuous phenotype. Our results provided the first evidence that -197A (IL-17A) and 7488T (IL-17F) alleles may influence the susceptibility to and pathophysiological features of UC independently.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828618     DOI: 10.1007/s10875-007-9125-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

3.  Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission.

Authors:  Makoto Tanaka; Keiko Kazuma
Journal:  J Clin Nurs       Date:  2005-01       Impact factor: 3.036

4.  IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.

Authors:  J Lee; W H Ho; M Maruoka; R T Corpuz; D T Baldwin; J S Foster; A D Goddard; D G Yansura; R L Vandlen; W I Wood; A L Gurney
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

5.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Authors:  D Matusevicius; P Kivisäkk; B He; N Kostulas; V Ozenci; S Fredrikson; H Link
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

6.  GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice.

Authors:  L Santucci; M Agostini; S Bruscoli; A Mencarelli; S Ronchetti; E Ayroldi; A Morelli; M Baldoni; C Riccardi
Journal:  Gut       Date:  2006-06-08       Impact factor: 23.059

Review 7.  After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?

Authors:  Zili Zhang; David J Hinrichs; Huiying Lu; Hong Chen; Wenwei Zhong; Jay K Kolls
Journal:  Int Immunopharmacol       Date:  2006-11-13       Impact factor: 4.932

Review 8.  Critical role for IL-15 in innate immunity.

Authors:  Toshiaki Ohteki
Journal:  Curr Mol Med       Date:  2002-06       Impact factor: 2.222

9.  IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis.

Authors:  M Chabaud; E Lubberts; L Joosten; W van Den Berg; P Miossec
Journal:  Arthritis Res       Date:  2001-01-26

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  58 in total

1.  A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.

Authors:  Federico Innocenti; Kouros Owzar; Nancy L Cox; Patrick Evans; Michiaki Kubo; Hitoshi Zembutsu; Chen Jiang; Donna Hollis; Taisei Mushiroda; Liang Li; Paula Friedman; Liewei Wang; Dylan Glubb; Herbert Hurwitz; Kathleen M Giacomini; Howard L McLeod; Richard M Goldberg; Richard L Schilsky; Hedy L Kindler; Yusuke Nakamura; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

2.  IL-17A G197A gene polymorphism contributes to susceptibility for liver cirrhosis development from patients with chronic hepatitis B infection in Chinese population.

Authors:  Jian Ge; Yuan-Zi Yu; Tao Li; Zhao-Yang Guo; Hao Wu; Shao-Can Tang; Xin-Guang Liu; Qiang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort.

Authors:  N Senhaji; A Serrano; W Badre; N Serbati; M Karkouri; Y Zaid; S Nadifi; J Martin
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

4.  Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population.

Authors:  Xiaofei Zhang; Pengli Yu; Ying Wang; Wenyu Jiang; Fangcheng Shen; Yamin Wang; Huiming Tu; Xiaozhong Yang; Ruihua Shi; Hongjie Zhang
Journal:  Inflamm Res       Date:  2013-05-08       Impact factor: 4.575

Review 5.  IL-17 and limits of success.

Authors:  Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cell Immunol       Date:  2018-09-17       Impact factor: 4.868

6.  -449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis.

Authors:  Ranji Hayashi; Tomomitsu Tahara; Tsukasa Yamaaki; Takashi Saito; Kazuhiro Matsunaga; Nobuhiko Hayashi; Atsushi Fukumura; Kazuaki Ozaki; Masakatsu Nakamura; Hisakazu Shiroeda; Mikihiro Tsutsumi; Tomoyuki Shibata; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis.

Authors:  Jiehua Chen; Yu Deng; Jing Zhao; Zhengxiu Luo; Wansheng Peng; Juan Yang; Luo Ren; Lijia Wang; Zhou Fu; Xiqiang Yang; Enmei Liu
Journal:  J Clin Immunol       Date:  2010-05-02       Impact factor: 8.317

8.  IL17RA gene variants and anti-TNF response among psoriasis patients.

Authors:  A Batalla; E Coto; J Gómez; N Eirís; D González-Fernández; C Gómez-De Castro; E Daudén; M Llamas-Velasco; R Prieto-Perez; F Abad-Santos; G Carretero; F S García; Y B Godoy; L F Cardo; B Alonso; S Iglesias; P Coto-Segura
Journal:  Pharmacogenomics J       Date:  2016-09-27       Impact factor: 3.550

Review 9.  IL-17F: regulation, signaling and function in inflammation.

Authors:  Seon Hee Chang; Chen Dong
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

10.  Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population.

Authors:  Xukui Zhang; Luming Zheng; Yinggang Sun; Xiaoqiao Zhang
Journal:  Tumour Biol       Date:  2013-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.